VEV Healthcare Store

Wednesday, May 3, 2023

$18.89 - REGENERUM Regenerative Lip Peeling 5G — Made in Poland by Aflofarm — Free Delivery

Aflofarm #To_the_mouth #Lipsticks_and_sticks #COSMETICS

Product description

Lip Regenerum stimulates microcirculation thanks to the use of exfoliating ingredients. The cosmetic prepares lips to apply lipstick or lip gloss, extends their durability and facilitates even application. Cosmetic formula:

regenerates even very chapped and cracked skin,
firms the skin of the lips,
protects against the negative effects of sun, frost and wind.

The active ingredients in the product restore your lips to their proper color, nourish the skin and allow you to use even the most durable matte lipsticks.

Application

Daily care for chapped skin of the lips that requires smoothing and regeneration.

Usage method

Apply the right amount of stick peeling directly to the lips until the desired effect is achieved.

You can wipe off any excess product.

Can be used daily.

Ingredients (INCI)

Ethylhexyl Palmitate, Polyisobutene, Paraffin, Cera Microcristallina, Bis-Diglyceryl Polyacyladipate-2, Hydrogenated Coco-Glycerides, Hydrated Silica, C30-45 Alkyl Methicone, Tocopheryl Acetate, C30-45 Shefini Butter (Butterspermum Shefini) , Parfum, Silica Dimethyl Silylate, Prunus Amygdalus Dulcis Oil (sweet almond oil), Diethylhexyl Syringylidenemalonate, Persea Gratissima Fruit Extract (avocado extract), Caprylyl Glycol, Glycine Soja Oil (soybean oil), Caprylic / Capriceric Triglyceric Triglycerin, Caprylic / CapricericTriglyclyceric (glycerin), Tocopherol (vitamin E), Beta-Sitosterol, Squalene (squalene).

Additional information

Do not use in case of hypersensitivity to any of the ingredients of the preparation.

Store in a dry place at 8-25 ° C.

Protect against direct sunlight.

$18.89 BUY ONLINE
MORE

$23.09 - Amicitron without sugar 13g x 10 sachets — Made in Ukraine — Free Delivery

InterChem #Colds_and_flu #Fever #HEALTH_CARE

Pharmacological properties

Pharmacodynamics. Antipyretic, analgesic, antihistamine, vasoconstrictor combined agent, the action of which is due to the properties of the components that make up its composition.

Paracetamol has antipyretic, analgesic and anti-inflammatory effects. Paracetamol predominantly inhibits the synthesis of prostaglandins in the central nervous system and, to a lesser extent, affects the peripheral nervous system, blocking the conduction of pain impulses.

It is well absorbed, penetrates the placental barrier, enters breast milk in small amounts, is metabolized in the liver, excreted by the kidneys, T½ - 1–4 hours. The duration of action is 3-4 hours.

Pheniramine is an antihistamine, a blocker of histamine H1 receptors on effector cells, reduces vascular permeability, prevents the development of tissue edema, reduces the severity of local exudative processes, eliminates lacrimation, itching in the eyes and nose.

It is well absorbed, metabolized in the liver, excreted mainly by the kidneys, T1 / 2 - 16-18 hours.

Phenylephrine is a sympathomimetic that mainly stimulates α-adrenergic receptors, has a vasoconstrictor effect, reduces swelling of the nasal mucosa and paranasal sinuses.

Guaifenesin is an expectorant. It acts by increasing the volume and decreasing the viscosity of the secretion in the trachea and bronchi, which facilitates the secretion of sputum when coughing.

Pharmacokinetics. Paracetamol is rapidly and almost completely absorbed in the gastrointestinal tract. With oral administration, Cmax in blood plasma is reached 10-60 minutes after administration. 95% of paracetamol is metabolized in the liver by sulfo- and glucuroconjugation, as well as oxidation by the cytochrome P450 system. It is excreted by the kidneys, mainly in the form of metabolites, 3% of paracetamol is excreted unchanged. T½ is 1–4 hours. Paracetamol crosses the placental barrier, a small part of it passes into breast milk.

Guaifenesin is rapidly absorbed in the gastrointestinal tract. With oral administration, Cmax in blood plasma is achieved 15 minutes after administration. Guaifenesin is metabolized in the kidneys by oxidation to β- (2-methoxyphenoxide) lactic acid, an inactive metabolite that is excreted in the urine. T½ is 1 hour.

Phenylephrine hydrochloride is absorbed unevenly in the gastrointestinal tract and undergoes presystemic metabolism with the help of MAO in the intestine and liver. Thus, orally administered phenylephrine has reduced bioavailability. Cmax in blood plasma is achieved within 1-2 hours. T½ is 2-3 hours. It is excreted in the urine almost completely in the form of a sulfate conjugate.

Ascorbic acid compensates for the increased need for vitamin C in respiratory infections, enhances the body's nonspecific resistance. It is rapidly absorbed, metabolized in the liver, excreted by the kidneys.

Indications

Symptomatic treatment of acute respiratory infections and influenza: fever, headache, nasal congestion, runny nose, pain and muscle aches.

For preparations Amicitron plus and Amicitron plus without sugar also: productive cough with difficult sputum production.

Application

The preparation is prescribed for adults and children over the age of 14. are taken orally in the form of a solution. the contents of the sachet are dissolved in a glass of hot water (not boiling water). can be taken every 3-4 hours, but not more than 3 sachets per day. the maximum period of use without consulting a doctor is 3 days, further admission - on the recommendation of a doctor

Amicitron plus and Amicitron plus without sugar: apply orally in the form of a solution. Dissolve the contents of 1 sachet in 250 ml of hot water, but not boiling water. Use the prepared solution warm. Elderly adults, children over 12 years of age: 1 sachet every 4-6 hours if necessary. The maximum daily dose is 4 sachets. The maximum period of application without consulting a doctor is 3 days. If the symptoms of the disease persist, it is necessary to see a doctor. For children under 12 years of age, preparations are contraindicated.

Amicitron Extratab: adults and children over 12 years of age: 1 tablet every 4 hours. Drink with water. The maximum daily dose - 6 tablets - should not be exceeded. The maximum period of application without consulting a doctor is 3 days. Further use is possible only under medical supervision.

Contraindications

Hypersensitivity to the components of the preparation; pyloroduodenal obstruction; acute pancreatitis; severe impairment of liver and / or kidney function; congenital hyperbilirubinemia (including Zhilber's syndrome); deficiency of glucose-6-phosphate dehydrogenase; diabetes; hyperthyroidism; hypertrophy of the prostate with urinary retention; obstruction of the bladder neck; severe forms of arrhythmias, arrhythmias, atherosclerosis, coronary heart disease, blood diseases (including leukopenia, severe anemia); thrombosis; thrombophlebitis; ba; glaucoma; epilepsy; alcoholism, states of increased excitement; concomitant treatment with MAO inhibitors and a period of 2 weeks after discontinuation of their use.

Amicitron plus and Amicitron plus without sugar also: pheochromocytoma, phenylketonuria; rare hereditary problems associated with fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency. During pregnancy and breastfeeding. Age up to 12 years.

Do not use simultaneously with tricyclic antidepressants, paracetamol-containing preparations, β-adrenergic receptor blockers, sympathomimetics.

Side effects

On the part of the skin and subcutaneous tissue: dermatitis.

From the immune system: anaphylaxis, hypersensitivity reactions, including itching, rash on the skin and mucous membranes (usually generalized, erythematous rash, urticaria), angioedema, exudative erythema multiforme (including Stevens-Johnson syndrome), toxic epidermal necrolysis (toxic epidermal necrolysis syndrome) Lyell).

From the nervous system: headache, dizziness, tremor, psychomotor agitation and disorientation, anxiety, nervous irritability, fear, irritability, sleep disturbance, insomnia, drowsiness, confusion, hallucinations, depressions, paresthesias, tinnitus, in in some cases - coma, convulsions, dyskinesia, changes in behavior.

From the side of the organ of vision: visual impairment and accommodation, mydriasis, increased intraocular pressure, dry eyes.

From the respiratory system: bronchospasm in patients sensitive to acetylsalicylic acid and other NSAIDs.

From the digestive tract: nausea, vomiting, heartburn, dry mouth, discomfort and pain in the epigastric region, constipation, diarrhea, flatulence, aphthae, hypersalivation, hemorrhages.

From the hepatobiliary system: impaired liver function, increased activity of hepatic enzymes, usually without the development of jaundice, hepatonecrosis (when using high doses).

From the endocrine system: hypoglycemia, up to hypoglycemic coma.

From the urinary system: nephrotoxicity, interstitial nephritis, papillary necrosis, dysuria, urinary retention and difficulty urinating, aseptic pyuria.

From the side of the cardiovascular system: hypertension, arrhythmias (tachycardia, bradycardia, etc.), shortness of breath, pain in the heart.

From the blood and lymphatic system: anemia (including hemolytic anemia), sulfhemoglobinemia and methemoglobinemia (cyanosis, shortness of breath, pain in the heart), thrombocytopenia, agranulocytosis, bleeding, bruising.

Others: general weakness.

Special instructions

Do not exceed the recommended doses. in case of overdose, consult a doctor immediately due to the risk of liver damage, even if the patient is feeling well.

If you have an established intolerance to some sugars, you should consult your doctor before taking this medication. Amicitron contains sucrose, so the preparation should not be taken by patients with rare hereditary diseases associated with fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency. Amicitron contains sodium, so patients who follow a sodium-controlled diet should use this preparation with caution. The medicinal product contains FCF (E110) sunset yellow dye, which may cause allergic reactions.

Do not use simultaneously with other preparations intended for the symptomatic treatment of colds and rhinitis (vasoconstrictor, paracetamol-containing). Patients with mild arthritis who take analgesics every day, and patients who use warfarin or similar preparations that cause an anticoagulant effect, should consult a doctor before using the preparation.

In patients with severe infections such as sepsis, which are accompanied by a decrease in glutathione levels, the risk of metabolic acidosis increases with paracetamol. The symptoms of metabolic acidosis are deep, rapid or labored breathing, nausea, vomiting, and loss of appetite. You should immediately consult a doctor if these symptoms appear.

In case of liver or kidney disease, consult a doctor before using the preparation. It should be borne in mind that in patients with alcoholic non-cirrhotic lesions of the liver, the risk of the hepatotoxic effect of paracetamol increases.

Prescribe with caution for Raynaud's disease, hypertension, heart disease, arrhythmias (bradycardia, etc.), for prostatic hypertrophy, pheochromocytoma, for diseases of the thyroid gland, liver and kidneys, for glaucoma, chronic lung diseases and the elderly. The preparation contains phenylephrine, which can lead to angina attacks.

The preparation may affect the results of laboratory tests on the content of glucose and uric acid in the blood.

If symptoms persist (in particular if the headache becomes persistent), you should see your doctor.

Long-term use of the preparation without consulting a doctor can be dangerous.

Amicitron Plus and Amicitron Plus Sugar Free contain aspartame (E951), a source of phenylalanine that is dangerous for people with phenylketonuria.

Use during pregnancy and lactation. Do not use.

The ability to influence the reaction rate when driving or working with other mechanisms. When using Amicitron, it is not recommended to drive a car or work with other mechanisms, since the preparation may cause dizziness, drowsiness.

Interactions

The absorption rate of paracetamol may increase with the use of metoclopramide and domperidone and decrease with the use of cholestyramine. barbiturates reduce the severity of the antipyretic effect of paracetamol. anticonvulsants (including phenytoin, barbiturates, carbamazepine), which stimulate the activity of microsomal liver enzymes, can increase the toxic effect of paracetamol on the liver due to an increase in its conversion to hepatotoxic metabolites. with the simultaneous use of paracetamol with hepatotoxic agents, the toxic effect of preparations on the liver increases. the simultaneous use of paracetamol in high doses with isoniazid increases the risk of developing hepatotoxic syndrome. the anticoagulant effect of warfarin and other coumarins may increase with the simultaneous long-term regular daily use of paracetamol with an increased risk of bleeding; periodic intake does not cause significant effect. paracetamol reduces the effectiveness of diuretics. do not use simultaneously with alcohol.

The interaction of phenylephrine with MAO inhibitors causes a hypertensive effect, tricyclic antidepressants (amitriptyline) - increases the risk of cardiovascular side effects, digoxin and cardiac glycosides - leads to arrhythmias and heart attack. Phenylephrine with other sympathomimetics increases the risk of adverse cardiovascular reactions, may reduce the effectiveness of β-adrenergic receptor blockers and other antihypertensive preparations (reserpine, methyldopa) with an increased risk of hypertension and adverse cardiovascular reactions.

Pheniramine enhances the anticholinergic effect of atropine, antispasmodics, tricyclic antidepressants, antiparkinsonian preparations. The simultaneous use of feniramine with hypnotics, barbiturates, sedatives, antipsychotics, tranquilizers, anesthetics, narcotic analgesics, alcohol can significantly increase the severity of its inhibitory effect.

When taken orally, ascorbic acid enhances the absorption of penicillin, iron, reduces the effectiveness of heparin and indirect anticoagulants, increases the risk of crystalluria in the treatment of salicylates and the risk of glaucoma in the treatment of corticosteroids, in high doses reduces the effectiveness of tricyclic antidepressants. Antidepressants, antiparkinsonian and antipsychotic preparations, phenothiazine derivatives increase the risk of urinary retention, dry mouth, and constipation. Ascorbic acid can be taken only 2 hours after the injection of deferoxamine, since their simultaneous intake increases the toxicity of iron, especially in the myocardium. Long-term use in high doses during treatment with disulfiram inhibits the disulfiram-alcohol reaction.

Guaifenesin enhances the effect of sedatives and muscle relaxants.

Overdose

If the patient has taken the preparation in a dose higher than the recommended one, you should immediately consult a doctor because of the risk of liver damage. liver damage is possible in adults who have taken ≥10 g of paracetamol, and in children who have used paracetamol at a dose of 150 mg / kg body weight. taking ≥5 g of paracetamol can lead to liver damage in patients with risk factors (long-term use of carbamazepine, phenobarbital, phenytoin, primidone, rifampicin, St. eating behavior, HIV infection, starvation, cystic fibrosis, cachexia).

Symptoms of a paracetamol overdose in the first 24 hours: pallor, nausea, vomiting, loss of appetite and abdominal pain. Liver damage can occur 12–48 hours after an overdose. Disorders of glucose metabolism and metabolic acidosis may occur. In severe poisoning, liver failure can progress to encephalopathy, hemorrhage, hypoglycemia, coma, and death. ARF with acute tubular necrosis can present with severe lumbar pain, hematuria, proteinuria, and develop even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have also been reported.

With long-term use of paracetamol in high doses on the part of the hematopoietic organs, aplastic anemia, pancytopenia, agranulocytosis, leukopenia (including neutropenia), and thrombocytopenia may develop. When taken in high doses from the central nervous system, dizziness, psychomotor agitation, disorientation, sleep disturbance are possible; from the urinary system - nephrotoxicity (renal colic, interstitial nephritis, papillary necrosis).

In case of an overdose, an ambulance is needed. The patient should be taken to hospital immediately, even if there are no early symptoms of overdose. Symptoms may be limited to nausea and vomiting, or may not reflect the severity of the overdose or the risk of organ damage. Treatment with activated charcoal should be considered if an excessive dose of paracetamol has been taken within 1 hour. The plasma concentration of paracetamol should be measured 4 hours or later after ingestion (earlier concentrations are unreliable). Treatment with N-acetylcysteine can be applied within 24 hours after taking paracetamol, but the maximum protective effect occurs when it is used within 8 hours after administration. The effectiveness of the antidote decreases sharply after this time. If necessary, the patient should be injected intravenously with N-acetylcysteine according to the current recommendations. In the absence of vomiting, oral methionine can be used as an appropriate alternative in remote areas outside the hospital.

In case of an overdose of phenylephrine, hyperhidrosis, psychomotor agitation or depression of the central nervous system, headache, dizziness, drowsiness, impaired consciousness, arrhythmias, tremors, hyperreflexia, convulsions, nausea, vomiting, irritability, anxiety, hypertension occur.

With an overdose of pheniramine, atropine-like symptoms occur: mydriasis, photophobia, dry skin and mucous membranes, hyperthermia, intestinal atony. Inhibition of the central nervous system leads to disruption of the respiratory and cardiovascular systems (bradycardia, arterial hypotension, collapse).

In case of an overdose of ascorbic acid, nausea, vomiting, bloating and abdominal pain, itching, skin rashes, and increased excitability occur. Doses of 3000 mg can cause temporary osmotic diarrhea and gastrointestinal disorders, impaired metabolism of zinc, copper, myocardial dystrophy, glucosuria, crystalluria, nephrolithiasis.

Guaifenesin. Overdose in small or moderate doses can cause dizziness or vertigo, gastrointestinal disturbances (in particular, nausea, vomiting). Very high doses can cause symptoms such as agitation, confusion, and respiratory depression.

Treatment: symptomatic therapy. Within 6 hours after an overdose, gastric lavage should be performed, and within the first 8 hours, methionine or intravenous cysteamine or N-acetylcysteine should be administered orally.

Storage conditions

In its original packaging at a temperature not exceeding 25 ° c.

$23.09 BUY ONLINE
MORE

$22.04 - Isofra spray nasal 8000 IU/ml, 15ml — Made in France — Free Delivery

Sophartex #Colds_and_flu #Runny_nose_and_sinuses #HEALTH_CARE

Pharmacological properties

Pharmacodynamic parameters. Framycetin is a broad-spectrum aminoglycoside antibiotic for topical use. exposure to framycetin disrupts the synthesis of proteins vital for the functioning of the bacterial cell, which leads to the death of the microorganism.

Topical therapy with framycetin creates concentrations that have a bactericidal effect aimed at both gram-positive and gram-negative microorganisms - causative agents of infections of the upper respiratory tract.

The sensitivity to framycetin of corynebacteria, Branhamella catarrhalis, methicillin-sensitive staphylococci, acinetobacteria (mainly Acinetobacter baumanii), E. coli, campylobacter, representatives of the genus citrobacter (Citroesbacter freundii, , proteoses (Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri); Klebsiella, Salmonella, Shigella, Yersinia and Serrata are also sensitive.

There is a moderately pronounced activity of framycetin against the causative agents of pasteurellosis.

Framycetin is resistant to enterococci, streptococci, methicillin-resistant staphylococci (more hospital strains), Pseudomonas aeruginosa, Nocardia asteroides, flavobacteria, Alcaligenes denitrificans, Providencia stuartii, burkholderias, mycilliopathies, Stenotrophiliaceae, which are not required for the presence of mycosis, Stenotrophilia oxygen.

Indications

Diseases of the upper respiratory tract of an infectious and inflammatory nature (as part of a combination treatment): rhinitis, rhinopharyngitis, sinusitis (in the case of intact walls of the paranasal sinuses); inflammatory processes after surgery (therapy and prevention).

Application

1 injection in each nasal passage (adults - 4-6 times a day, children over the age of 1 year - 3 times a day). course - up to 10 days.

When using, observe the vertical position of the bottle; the patient's head should be slightly tilted forward.

Contraindications

Hypersensitivity to framycetin (as well as other aminoglycosides) or other components of the preparation; children aged 1 year.

Side effects

In rare cases, allergic reactions are possible: itching, urticaria.

Special instructions

Do not use as a sinus rinse.

In a situation of prolonged use of the preparation, the development of antibiotic-resistant strains of microorganisms is likely.

If there is no effect of therapy within 7 days, the preparation should be discontinued.

Do not use during pregnancy and lactation.

There was no effect on the reaction rate when driving vehicles or other mechanisms.

Interactions

No data available.

It is necessary to inform the doctor if the patient is using any other topical preparations.

Overdose

Not found.

Storage conditions

At a temperature of ≤25 ° C, out of the reach of children.

$22.04 BUY ONLINE
MORE

$23.09 - Nifuroxazide Alkaloid 200 mg, 2p x 20 capsules — Made in Macedonia — Free Delivery

Alkaloid AD Skopje #Digestive_system #Diarrhea #HEALTH_CARE

Pharmacological properties

Pharmacodynamics. Nifuroxazide is a 5-nitrofuran derivative that acts exclusively in the intestinal lumen and is not absorbed from the gastrointestinal tract. local activity and the lack of penetration into the organs and tissues of the body determines the uniqueness of nifuroxazide in comparison with other nitrofuran derivatives, since there are no systemic effects. the mechanism of action of nifuroxazide is not fully understood. the antimicrobial and antiparasitic properties of nifuroxazide and other nitrofurantoin derivatives are due to the no2-group, which is most effective in the treatment of intestinal infections. the preparation is especially effective against gram-positive bacteria: streptococcus pyogenes, staphylococcus pyogenes and gram-negative bacteria: escherichia coli, salmonella and shigella.

Pharmacokinetics

Suction. After oral administration, the absorption of nifuroxazide in the gastrointestinal tract is extremely low, since more than 99% of the taken preparation remains in the intestine.

Distribution. Nifuroxazide is practically not absorbed from the digestive tract, and ultimately absorption does not exceed 0.005%, since there is no distribution to organs and tissues.

Metabolism. Biotransformation of nifuroxazide occurs in the intestine, only 20% of the administered amount of the preparation is excreted unchanged.

Excretion. Nifuroxazide and its metabolites are excreted completely in the feces. The rate of elimination depends on the amount of the preparation taken and the motility of the gastrointestinal tract.

Usually, elimination of nifuroxazide is slow, and the preparation remains in the digestive tract for a long time.

Indications

Acute diarrhea of infectious etiology.

Application

For oral administration.

Nifuroxazide Alkaloid capsules. Adults and children over the age of 12.

Adults: a single dose of 200 mg (or 2 capsules of 100 mg) 4 times a day.

Children (from 12 years old): 200 mg (or 2 capsules of 100 mg) 3-4 times a day (600-800 mg of nifuroxazide per day). The duration of treatment is no more than 7 days. If necessary, the use of the preparation can be extended depending on the clinical condition of the patient.

Nifuroxazide Alkaloid, suspension. The dose is set by means of a measuring cup. Shake the prepared suspension well before use!

Adults: 200 mg - 5 ml of suspension 4 times a day.

Children over 12 years of age: 5 ml 3-4 times a day (600-800 mg of nifuroxazide per day); children aged 2–12 years: 5 ml 3 times a day (600–800 mg of nifuroxazide per day). The duration of treatment is no more than 7 days.

Children. Children under the age of 12 are advised to use the preparation Nifuroxazide Alkaloid in the form of an oral suspension. Do not administer Nifuroxazide Alkaloid in the form of an oral suspension to children under 2 years of age.

Contraindications

Hypersensitivity to nitrofuran derivatives and / or preparation excipients.

Side effects

In patients with hypersensitivity to nitrofuran derivatives, granulocytopenia may occur; allergic reactions, usually of a skin type (skin rash, itching, urticaria, pustulosis). in isolated cases, as with the use of other nitrofuran derivatives, shortness of breath, severe hypersensitivity reactions, including angioedema and anaphylactic shock, may occur.

In case of severe adverse reactions, the preparation should be canceled and symptomatic therapy should be carried out. Further, the patient should avoid taking nifuroxazide and other nitrofuran derivatives.

On the part of the immune system: possible allergic reactions, including angioedema, urticaria and pruritus, reactions in the form of a skin rash, anaphylactic shock. The occurrence of an allergic reaction requires discontinuation of the preparation.

From the digestive system: individual cases of hypersensitivity to nifuroxazide are manifested by abdominal pain, nausea, vomiting and exacerbation of diarrhea. In the event of the appearance of such symptoms of low intensity, there is no need for special therapy or discontinuation of nifuroxazide, since the symptoms quickly disappear. If the exacerbation is severe, nifuroxazide should be discontinued.

Special instructions

If, during treatment with the preparation, the symptoms of diarrhea persist for more than 48 hours, the treatment should be reviewed and the use of the preparation should be evaluated.

The use of alcohol during therapy with nifuroxazide is prohibited due to the risk of developing a disulfiram-like reaction.

Treatment with nifuroxazide does not exclude dietary regimen and rehydration. If necessary, concomitant rehydration therapy should be used depending on the age and condition of the patient and the intensity of the diarrhea.

Rehydration should be a key element in the management of acute diarrhea in children. Children need to be provided with frequent (every 15 minutes) drinking.

Prevention or treatment of dehydration should be carried out by oral or intravenous solutions. If rehydration is prescribed, it is recommended to use solutions intended for this purpose, in accordance with the instructions for dilution and use. The amount of oral rehydration solutions provided depends on the weight loss. In case of severe diarrhea, intense vomiting and refusal to eat, IV rehydration is required.

If there is no need for such rehydration, it is necessary to compensate for the loss of fluid by drinking a large number of drinks containing salt and sugar (based on an average daily requirement of about 2 liters of water).

Consider dietary guidelines for diarrhea: avoid certain foods such as fresh vegetables and fruits, green vegetables, spicy foods, frozen foods and drinks. Preference should be given to grilled rice and meat. The decision to use dairy products should be made on a case-by-case basis.

If diarrhea is accompanied by clinical manifestations that indicate the progression of the condition (deterioration of the general condition, fever, symptoms of intoxication), nifuroxazide should be prescribed together with antibacterial preparations of systemic action, which are used to treat intestinal infections, since it is not absorbed in the intestine and does not enter the systemic circulation ...

The preparation should not be prescribed as monotherapy for the treatment of intestinal infections complicated by septicemia.

In the event of a hypersensitivity reaction (shortness of breath, swelling of the face, lips, tongue, skin rashes, itching), you should immediately stop taking nifuroxazide.

The preparation in the form of capsules contains FCF sunset yellow dye, which can cause allergic reactions.

The suspension formulation contains sorbitol. If a patient has an established intolerance to some sugars, a doctor should be consulted before using this medication.

Application during pregnancy or lactation. In animal studies, no teratogenic effects have been identified. There is not enough substantiated data to assess the possible teratogenic or fetotoxic effect when using nifuroxazide during pregnancy. Therefore, as a precautionary measure, it is recommended to avoid the use of nifuroxazide during pregnancy (it can be used in women during breastfeeding, subject to short-term treatment).

The ability to influence the reaction rate when driving vehicles or other mechanisms. Does not affect.

Interactions

Nifuroxazide can be used in combination with preparations commonly used to treat diarrhea: rehydration solutions, antibiotics, chemotherapy preparations, antispasmodics, and pain relievers.

The use of nifuroxazide with CNS depressants and preparations that may cause addiction is not recommended.

Concomitant use of other oral medicinal products should be avoided due to the strong adsorption properties of nifuroxazide.

Nifuroxazide is not recommended to be used simultaneously with sorbents, preparations that contain alcohol, agents that can cause antabuse reactions.

During treatment with nifuroxazide, alcohol consumption is strictly prohibited due to the possibility of a disulfiram-like reaction, which is manifested by exacerbation of diarrhea, vomiting, abdominal pain, a feeling of heat in the face and upper body, flushing, tinnitus, difficulty breathing, tachycardia.

Overdose

Overdose symptoms are not described. in case of suspicion of an overdose of nifuroxazide, the patient's condition should be carefully monitored, and supportive and symptomatic treatment should be prescribed.

Storage conditions

In original packaging. capsules - at a temperature not exceeding 30 ° c. suspension - at a temperature not exceeding 25 ° c.

$23.09 BUY ONLINE
MORE

$53.54 - Konegra Deluxe 100 mg 8 tablets — Made in Greece — Free Delivery

Genepharm S.A. #Health #Potency #FOR_HIM

Product description

Konegra Deluxe tablets are indicated for the treatment of erectile dysfunction, which is defined as the inability to achieve and maintain an erection of the penis necessary for successful intercourse.

For the effective action of the preparation Konegra Deluxe, you need sexual arousal.

Compound

Active substance: sildenafil;

1 chewable tablet contains sildenafil citrate 35.12 mg equivalent to sildenafil 25 mg;

1 chewable tablet contains 70.24 mg of sildenafil citrate equivalent to 50 mg of sildenafil;

1 chewable tablet contains sildenafil citrate 140.48 mg equivalent to sildenafil 100 mg;

Excipients: potassium polacrilin; purified water potassium hydroxide or hydrochloric acid; magnesium stearate silicon dioxide colloidal aspartame (E 951) croscarmellose sodium; mint flavor; lactose monohydrate, povidone K-30.

Contraindications

Hypersensitivity to the active substance or any of the excipients of the preparation.

Concomitant use with nitric oxide donors (such as amyl nitrite) or nitrates in any form is contraindicated, since it is known that sildenafil affects the pathways of nitric oxide / cyclic guanosine monophosphate (cGMP) metabolism and potentiates the hypotensive effect of nitrates.

The simultaneous use of PDE-5 inhibitors (including sildenafil) with guanylate cyclase stimulants, such as riociguat, is contraindicated because it can lead to symptomatic hypotension.

Conditions for which sexual activity is not recommended (for example, severe cardiovascular disorders such as unstable angina or severe heart failure).

Loss of vision in one eye due to non-arterial anterior ischemic neuropathy of the optic nerve, regardless of whether this pathology is associated with previous use of PDE-5 inhibitors or not.

The presence of such diseases: severe liver dysfunction, arterial hypotension (blood pressure below 90/50 mm Hg).

Recently suffered stroke or myocardial infarction and known hereditary degenerative retinal diseases such as retinitis pigmentosa (a small number of such patients have genetic disorders of the retinal PDE), since the safety of sildenafil has not been studied in the case of such diseases.

Mode of application

The preparation is administered orally. Chew the tablet before swallowing.

For the effective action of the preparation, you need sexual arousal.

Adults. The recommended dose is 50 mg and is applied, if necessary, about an hour before intercourse. Depending on the effectiveness and tolerability of the preparation, the dose can be increased to 100 mg or reduced to 25 mg. The maximum recommended dose is 100 mg.

The maximum recommended frequency of use of the preparation is 1 time per day. When using the preparation during a meal, the effect of the preparation may occur later than when it is used on an empty stomach.

Application features

Pregnant

Not intended for use by women.

Children

The preparation is indicated for use by persons under the age of 18.

Drivers

Carefully.

Overdose

In studies involving volunteers, when using a single dose of sildenafil up to 800 mg, adverse reactions were similar to those observed with the use of sildenafil at lower doses, but were more frequent and more severe. The use of sildenafil at a dose of 200 mg did not lead to an increase in efficacy, but caused an increase in the number of cases of adverse reactions (headache, flushing, dizziness, dyspepsia, nasal congestion, visual disturbances).

In case of overdose, if necessary, resort to the usual supportive measures. An acceleration of the clearance of sildenafil during hemodialysis is unlikely due to the high degree of binding of the preparation to blood plasma proteins and the lack of elimination of sildenafil in the urine.

Side effects

The most commonly reported adverse reactions were headache, flushing, dyspepsia, nasal congestion, back pain, dizziness, nausea, hot flashes, visual disturbances, cyanopsia, and blurred vision.

Interaction

Sildenafil metabolism occurs predominantly with the participation of the ZA4 isoform (major pathway) and the 2C9 isoform (minor pathway) of cytochrome P450 (CYP). Therefore, inhibitors of these isoenzymes can reduce the clearance of sildenafil, and inducers of these isoenzymes can increase the clearance of sildenafil.

Storage conditions

The preparation does not require special temperature storage conditions.

Store in original packaging to protect from light.

Keep out of the reach of children.

Shelf life is 3 years.

$53.54 BUY ONLINE
MORE

$16.79 - Ambroxol-Teva oral solution 7.5mg/ml 40 ml — Made in Germany — Free Delivery

TEVA #Colds_and_flu #Cough #HEALTH_CARE

Pharmacological properties

Ambroxol-Teva oral solution is used for secretolytic therapy for acute and chronic broncho-pulmonary diseases associated with impaired bronchial secretion and weakening of mucus movement.

Structure

Active ingredient: ambroxol hydrochloride.

1 ml of ambroxol hydrochloride - 7.5 mg;

Excipients: potassium sorbate (E 202), diluted hydrochloric acid (25%), purified water.

Contraindications

Hypersensitivity to ambroxol and / or other components of the preparation.

Mode of application

Take orally after meals. Dispense the preparation using a dosing cup. Take the drops after meals, dissolved in a liquid (for example, water, tea or juice).

The mucolytic effect of Ambroxol is enhanced by the use of large amounts of liquid.

The duration of treatment depends on the characteristics of the course of the disease.

Ambroxol-Teva solution should not be used for more than 4-5 days without consulting a doctor.

In case of impaired renal function and severe liver disease, the preparation can be taken only under the supervision of a doctor. In this case, it is recommended to reduce the dose and increase the time between doses of the preparation.

In acute illnesses, you should consult a doctor if symptoms persist and / or worsen despite taking Ambroxol-Teva.

Application features

Pregnant

It is not recommended to use the preparation in the first trimester of pregnancy.

Children

The preparation can be used in pediatric practice. For children under 2 years of age, use as directed by a doctor.

Overdose

There are currently no reports of specific overdose symptoms. Symptoms known from rare reports of overdose and / or cases of misuse of preparations correspond to the known side effects of Ambroxol hydrochloride in recommended doses and require symptomatic treatment.

Side effects

Skin rash, urticaria, angioedema, pruritus, anaphylactic reactions (including anaphylactic shock), other hypersensitivity reactions, dysgeusia (taste disorder), nausea, decreased sensitivity in the mouth, vomiting, diarrhea, dyspepsia, abdominal pain, dry mouth, drooling, dry throat, decreased sensitivity in the pharynx, shortness of breath (as a symptom of a hypersensitivity reaction).

Interaction

The simultaneous use of the preparation and cough suppressants can lead to excessive accumulation of mucus due to inhibition of the cough reflex, therefore such a combination is possible only after a doctor's careful assessment of the ratio of the expected benefit and the possible risk of use.

Storage conditions

The preparation does not require special storage conditions.

Keep out of the reach of children.

The shelf life is 5 years.

$16.79 BUY ONLINE
MORE

$18.89 - CLOTIDAL CREAM 35G — MADE IN POLAND — FREE SHIPPING

USP ZDROWIE #Urogenital_tract #Vaginal_infections_and_irritations #HEALTH_CARE

Indications

Treatment of fungal inflammation (yeast infection) of the mucous membranes of the genital organs (vulvovaginitis, vaginitis, infection of the glans penis). The preparation is indicated in patients under 16 years of age.

Composition

The active substance is clotrimazole: 1 g of vaginal cream contains 10 mg of clotrimazole. The other ingredients are: cetyl palmitate, octyldodecanol, polysorbate 60, sorbitan stearate, benzyl alcohol, cetostearyl alcohol, purified water. Packaging: tube and 6 vaginal applicators, 5 ml each, in a cardboard box.

Action

The active substance of the preparation clotrimazole has an antifungal activity; the cream relieves the symptoms of vaginal yeast infection and penile inflammation.

Dosage

Unless your doctor tells you otherwise, the preparation should be used once a day, at bedtime, for 6 consecutive days as follows: fully extend the applicator plunger until you feel resistance, open the tube and connect the applicator with the tube. Holding them together, fill the applicator by gently squeezing the tube. Detach the applicator from the tube. Insert the applicator as deep into the vagina as possible (preferably in a lying position with slightly bent legs) and push the plunger until the content of the applicator is completely empty. Remove the applicator and discard. You should wash your hands before and after using the medicine. The preparation should be used vaginally for 6 consecutive days. Infection of the glans penis (tip of the penis) by yeast (Candida): apply a thin layer of the preparation 2 to 3 times a day to the affected area, rubbing gently. The typical treatment period is 1 to 2 weeks.

Contraindications

If you are allergic to clotrimazole or any of the other ingredients of this medicine, Clotidal may affect the action of oral medications containing tacrolimus or sirolimus. Clotidal also reduces the effectiveness of amphotericin and other polyene antibiotics (e.g., nasal, natamycin). Concomitant topical preparations containing strong steroids reduce the effect of Clotidal. Do not use the preparation during pregnancy, stop breastfeeding during treatment with Clotidal, it may cause local skin reactions, do not use the preparation during menstruation, do not use tampons, vaginal irrigation, spermicides or other vaginal preparations.

The preparation may reduce the effectiveness and safety of latex products. Therefore, additional contraceptive measures should be taken while taking Clotidal.

Additional information

Before use, read the leaflet, which contains indications, contraindications, data on side effects, dosage and information on the use of the medicinal product, or consult your doctor or pharmacist, as each preparation used improperly is a threat to your life or health.

$18.89 BUY ONLINE
MORE

Tuesday, May 2, 2023

$15.74 - Metformin-Teva 1000mg 30 tablets — Made in Hungary — Free Delivery

TEVA #For_diabetics #Sugar_level_regulation #HEALTH_CARE

Product description

Tablets "Metformin-Teva" are used for the following indications:

type 2 diabetes mellitus with ineffective diet and exercise regimen, especially in overweight patients (as monotherapy or combination therapy in conjunction with other oral hypoglycemic agents or in conjunction with insulin for the treatment of adults; as monotherapy or combination therapy with insulin for treatment children over the age of 10 and adolescents);
reduction of diabetes complications in adult patients with type 2 diabetes mellitus and overweight who used metformin as a first-line drug with ineffective dietary therapy.

Structure

The active ingredient is metformin hydrochloride (one tablet contains 1000 mg of metformin hydrochloride).

Excipients: povidone K-30, anhydrous colloidal silicon dioxide, magnesium stearate, white opadry Y-1-7000 (hypromellose, titanium dioxide (E 171), macrogol).

Contraindications

hypersensitivity to metformin or to any other component of the drug;
any type of acute metabolic acidosis (eg, lactic acidosis, diabetic ketoacidosis);
diabetic precoma;
severe renal impairment (GFR <30 ml / minute);
acute conditions occurring with the risk of developing impaired renal function: dehydration, severe infectious diseases, shock;
diseases that can lead to the development of tissue hypoxia (especially acute diseases or exacerbations of a chronic disease): decompensated heart failure, respiratory failure, recent myocardial infarction, shock;
liver failure;
acute alcohol intoxication, alcoholism.

Mode of application

Adults

Monotherapy or combination therapy in conjunction with other oral hypoglycemic agents. Usually, the initial dose is 500 mg or 850 mg (use in the appropriate dosage) of metformin hydrochloride 2-3 times a day during or after meals. After 10-15 days, the dose must be adjusted according to the results of measurements of the glucose level in the blood serum. Slowly increasing the dose helps to reduce side effects from the digestive tract. The maximum recommended dose is 3000 mg / day, divided into 3 doses. If you switch from another antidiabetic drug, you must stop taking this drug and prescribe metformin as described above.

Combination therapy in combination with insulin. Metformin and insulin can be used in combination therapy to achieve better blood glucose control. The usual starting dose is 500 mg or 850 mg (to be used at the appropriate dosage) of metformin hydrochloride 2-3 times a day, while the dose of insulin should be adjusted according to the results of blood glucose measurements.

Children

Monotherapy or combination therapy with insulin. Metformin hydrochloride should be used in children over 10 years of age and adolescents. Usually, the initial dose is 500 mg or 850 mg (use in the appropriate dosage) of metformin hydrochloride 1 time per day during or after meals. After 10-15 days, the dose must be adjusted according to the results of measurements of the glucose level in the blood serum. Slowly increasing the dose helps to reduce side effects from the digestive tract. The maximum recommended dose is 2000 mg / day, divided into 2-3 doses.

Application features

Pregnant

Uncontrolled diabetes during pregnancy (gestational or permanent) increases the risk of congenital anomalies and perinatal mortality. There are limited data on the use of metformin in pregnant women, which does not indicate an increased risk of congenital anomalies. Animal studies have shown no adverse effects on pregnancy, embryo or fetal development, childbirth and postpartum development. In the case of planning pregnancy, as well as in case of pregnancy, it is recommended to use metformin for the treatment of diabetes, and insulin to maintain blood glucose levels as close to normal as possible to reduce the risk of developing fetal malformations.

Metformin passes into breast milk, but no side effects have been observed in breastfed neonates / infants. However, since there is insufficient data on the safety of using metformin during breastfeeding, its use is not recommended during this period. The decision to stop breastfeeding should be made with the benefits of breastfeeding and the potential risk of side effects to the baby in mind.

Metformin did not affect the fertility of animals when used in doses of 600 mg / kg / day, which is almost 3 times higher than the maximum recommended daily dose for humans based on body surface area.

Drivers

Monotherapy with metformin does not affect the reaction rate when driving or operating other mechanisms, since the drug does not cause hypoglycemia.

However, care should be taken when using metformin in combination with other hypoglycemic agents (sulfonylurea derivatives, insulin or meglitinides) because of the risk of hypoglycemia.

Overdose

When using the drug at a dose of 85 g, the development of hypoglycemia was not observed. However, in this case, the development of lactic acidosis was observed. A significant excess of the dose of metformin or associated risk factors can lead to the occurrence of lactic acidosis. Lactic acidosis is a medical emergency and should be treated in a hospital. The most effective measure for removing lactate and metformin from the body is hemodialysis.

Side effects

Frequent adverse reactions, especially at the beginning of treatment, are nausea, vomiting, diarrhea, abdominal pain, and lack of appetite.

Storage conditions

Special storage conditions are not provided. Keep out of the reach of children.

Shelf life is 3 years.

$15.74 BUY ONLINE
MORE

$38.84 - Doloriva OD 30 capsules — Made in Slovenia — Free Delivery

ErgoPharma #The_nervous_system #Nervous_system_support #HEALTH_CARE

Product description

Dietary supplement Doloriva OD contributes to the normal functioning of the nervous system.

Recommendations for use: it can be recommended as an additional source of nutrients: uridine, cytidine and vitamins B1, B6, B12 and D3.

The components of Doloriva OD help to reduce tension and feeling of stiffness in the muscles. An effective combination of components contributes to the normal functioning of the nervous system, an increase in energy metabolism in cells, a decrease in fatigue and fatigue, and normal psychological activity.

Uridine and cytidine are natural building materials that promote the regeneration of nerve cells.

B vitamins - essential coenzymes of various metabolic reactions, contribute to the normal functioning of the nervous system and energy metabolism, reduce fatigue and fatigue.

Vitamin B12 plays a role in the process of cell division, which is important incl. for tissue regeneration processes.

Vitamin D contributes to the normal absorption / assimilation of calcium and phosphorus and the maintenance of normal muscle function.

What happens when nerves are damaged?

Burning, numbness, tingling - all this can be the result of damage to the fibers of the peripheral nerves, in particular the myelin sheath. The myelin sheath is needed to electrically isolate nerve cells from the action of other cells and to transmit their own impulses. With the destruction of the insulating myelin layer, the speed of signal transmission along the nerve fibers slows down and pain occurs. The main causes of damage to peripheral nerves are: prolonged metabolic disorders, compression and pinching of nerves, including due to injuries, a sedentary lifestyle, inflammatory processes in the body.

The restoration of damaged nerve structures takes a long time and requires certain components. Nerve cells need a daily supply of nutrients.

DolorivaOD contains biogenic elements uridine monophosphate (UMP), cytidine monophosphate (CMP), vitamins B1, B6, B12 and D3, which stimulate the body's own recovery processes.

The action of Doloriva OD is due to the effects of the active substances that make up its composition.

Active ingredients

CMF is involved in the synthesis of a complex of lipids that form the neuronal membrane, mainly sphingomyelin - the main component of the myelin sheath. Also, CMF is a precursor of nucleic acids (DNA and RNA), which, in turn, are the main elements of cellular metabolism. Studies show that in the early stages of peripheral nerve damage, the uptake of pyrimidine nucleotides such as uridine and cytidine is increased. CMF and UTP are involved in the synthesis of phospholipids and glycolipids, which mainly make up the myelin sheath and other nerve structures. This promotes intense metabolic activity, which in turn contributes to the regeneration of the myelin sheath. Thus, the combination of the action of CMF and UMF promotes: regeneration of the myelin sheath, conduction of nervous excitement, restoration of muscular trophism and reduction of pain syndrome.

Vitamins B1, B6, B12 play an important role in maintaining neuronal metabolism (protein biosynthesis, myelination processes). In particular, vitamin B12 is involved in the formation of the myelin layer. Also involved in the stages of synthesis of purine and pyrimidine nucleic bases, nucleic acids and proteins.

Composition

Hard gelatin capsule (gelatin, titanium dioxide), corn starch filler, cytidine 5'-monophosphate disodium salt, uridine 5'-monophosphate disodium salt, magnesium stearate and silicon dioxide anti-caking agent, talc glidant, pyridoxine hydrochloride, granoxine hydrochloride, granoxine hydrochloride cyanocobalamin. Without GMO.

1 capsule contains:

Cytidine monophosphate - 30.0 mg (mg)

Uridine monophosphate - 30.0 mg (mg)

Vitamin B6 - 1.4 mg (mg)

Vitamin B1 - 1.1 mg (mg)

Vitamin B12 - 4 μg (μg)

Vitamin D3 - 15 μg (μg) - 600 IU (MO)

Caution when consuming

Individual intolerance to the components of the product. Do not use for children under 18 years of age, pregnant women and breastfeeding women. This product is not intended for diagnosis or treatment, and should not be used as a substitute for a complete diet. Do not exceed the recommended daily dose. It is recommended to consult a doctor before use.

Method of administration and recommended daily dose

Adults take 1 capsule per day.

Consumption period: 4 weeks, further consumption should be discussed with your doctor.

Storage conditions

Store in a dry, dark place and out of reach of children, at a temperature of 15-25 ° C.

Expiration date: 24 months from the date of production.

$38.84 BUY ONLINE
MORE

$23.09 - Dermovate ointment 0.05% 25g — Made in Poland — Free Delivery

GlaxoSmithKline #Dermatology #Diseases #Psoriasis #HEALTH_CARE

Indications

Psoriasis (with the exception of widespread plaque psoriasis), dermatoses that are difficult to treat, lichen planus, discoid lupus erythematosus and other diseases that cannot be treated with less active corticosteroids.

Application

Ointment or cream is applied in a thin layer to the affected areas of the skin 1 or 2 times a day. when control of the disease is achieved, the use of clobetasol should be gradually discontinued. in conditions of a good response to treatment, control of the disease can be achieved in a few days. treatment should not last more than 4 weeks. the maximum dose should not exceed 50 g per week. if there is no improvement within 2–4 weeks, the diagnosis and treatment should be reassessed. to control exacerbations, repeated short courses of therapy with Dermovate can be carried out. if long-term permanent treatment is necessary, less active corticosteroids should be used.

In resistant skin lesions, especially in the case of hyperkeratosis, the anti-inflammatory effect of Dermovate can be enhanced by covering the application site with plastic wrap. To achieve a positive result, an airtight bandage is applied all night. The already achieved effect is maintained by simply applying the preparation to the skin without film coating.

Contraindications

Hypersensitivity to the components of the preparation, untreated skin infections, rosacea, acne vulgaris, itching without inflammation, perianal and genital itching, perioral dermatitis. Dermovate is not indicated for the treatment of dermatoses in children under 1 year of age, including dermatitis and diaper rash.

Side effects

Side effects are classified by organs and systems and by frequency of occurrence. by frequency are distributed into the following categories: very often (≥1/10), often (≥1/100 and 1/10), infrequently (≥1/1000 and 1/100), rarely (≥1/10,000 and 1/100) 1000), very rarely (1/10,000, including isolated cases).

Infections and invasions: very rarely - opportunistic infections.

Immune system: very rarely - locally hypersensitivity.

Endocrine system: very rarely - depression of the hypothalamic-pituitary-adrenal system: cushingoid signs (for example, moon-like face, central obesity), delayed weight gain / height in children, osteoporosis, glaucoma, hyperglycemia / glucosuria, cataracts, hypertension, weight gain / obesity, decreased levels of endogenous cortisol, alopecia, brittle hair.

Skin and subcutaneous tissues: often - itching, local burning sensation / pain in the skin; infrequently - local skin atrophy *, atrophic stripes on the skin *, telangiectasias *; very rarely - thinning of the skin *, wrinkling of the skin *, drying of the skin *, pigmentation changes *, hypertrichosis, exacerbation of the main symptoms, allergic contact dermatitis / dermatitis, pustular psoriasis, erythema, rashes, urticaria, acne.

General disorders and disorders at the site of application: very rarely - irritation / pain at the site of application.

*Skin disorders secondary to local and/or systemic hypothalamic-pituitary-adrenal depression.

special instructions

The preparation is used with caution in the treatment of patients with a history of local hypersensitivity reactions to corticosteroids or other substances. local hypersensitivity reactions (see Adverse Reactions) may resemble the symptoms of the disease being treated.

The manifestation of hypercortisolism (Cushing's syndrome) and reverse suppression of the hypothalamic-pituitary-adrenal system with suppression of adrenal function in some patients may be the result of increased systemic absorption of topical steroids. In the event of any of the above symptoms, the use of the preparation should be gradually discontinued by reducing the frequency of application or replacing with a less strong corticosteroid. Sudden discontinuation of treatment may provoke glucocorticosteroid insufficiency (see ADVERSE REACTIONS).

Risk factors for systemic effects: potency and composition of the topical steroid; duration of application; application to a large area of the skin; application on skin surfaces that are in contact, for example, in areas of diaper rash or in places where an occlusive dressing is applied (in newborns, diapers can play the role of an occlusive dressing); increased hydration of the stratum corneum; use on areas with thin skin, such as the face; application on areas of damaged skin or under other conditions when the skin barrier is broken.

Compared with adults, children may absorb proportionally more topical corticosteroid and are therefore more susceptible to systemic adverse reactions. This is due to the fact that children have an underdeveloped skin barrier and a larger skin surface relative to body weight compared to adults.

Children. Where possible, long-term use of topical corticosteroids should be avoided in neonates and children under 12 years of age, as they are more likely to experience adrenal suppression.

Children are more likely to develop atrophic changes with topical corticosteroids. Treatment of children with Dermovate should, if possible, last no more than 5 days. The advisability of continuing treatment should be reviewed weekly.

Risk of infection when applying an occlusive dressing. The risk of bacterial infections increases in the warm and humid conditions that can occur under occlusive dressings, so the skin must be carefully cleaned before applying a new dressing.

Treatment of psoriasis. Topical corticosteroids should be used with caution in the treatment of psoriasis, as relapses, tolerance, the risk of generalization of pustular psoriasis, and the development of symptoms of local or systemic toxicity due to impaired skin barrier function have been reported in some cases. If used for the treatment of psoriasis, the patient should be under close medical supervision.

associated infections. Each time in the treatment of inflammatory lesions that become infected, it is necessary to prescribe the appropriate antibacterial preparations. If infection spreads, topical corticosteroids should be discontinued and appropriate antibiotic therapy instituted.

Chronic leg ulcers. Topical corticosteroids are sometimes used to treat dermatitis that occurs around chronic leg ulcers. However, such use is associated with an increased incidence of local hypersensitivity reactions and the risk of local infections.

Application to the face. Applying an ointment / cream to the skin of the face is undesirable, since this area is most prone to atrophic changes. If necessary, use should be limited to 5 days.

Application on the eyelids. When applying the ointment / cream on the eyelids, avoid getting the preparation into the eyes, since repeated use can provoke cataracts and glaucoma.

During pregnancy and breastfeeding

Pregnancy. There are limited data on the use of Dermovate in pregnant women.

Topical application of corticosteroids in pregnant animals can provoke intrauterine developmental disorders. There is no such data for humans. Dermovate should be used during pregnancy only if the expected benefit to the mother outweighs the risk to the fetus. Apply the minimum amount of the preparation during the minimum period of treatment.

Lactation. The safety of clobetasol propionate during lactation has not been established. It is not known whether the use of topical corticosteroids can lead to such systemic absorption, as a result of which a measurable amount of the preparation will be detected in breast milk. Dermovate should be used during lactation only if the expected benefit to the mother outweighs the risk to the baby. If Dermovate is prescribed during breastfeeding, the cream should not be applied to the breast to avoid accidental contact of the cream through the baby's mouth.

Influence on the ability to drive vehicles and work with other mechanisms. Studies on the study of such an effect have not been conducted. Taking into account the profile of adverse reactions, the effect on the reaction rate when driving a car or operating other mechanisms is not expected.

Interactions

It has been established that combined use with preparations that can inhibit cyp 3a4 (for example, ritonavir, itraconazole) inhibits the metabolism of corticosteroids, which can provoke a systemic effect. how this interaction is clinically significant depends on the dose of the preparation, the route of administration of corticosteroids and the power of the cyp 3a4 inhibitor.

Overdose

Symptoms and signs. with normal use, dermovate can be absorbed in quantities sufficient to cause a systemic effect. the likelihood of acute overdose is very low, however, in the case of chronic overdose or misuse, signs of hypercortisolism may occur.

Treatment. In case of overdose, Dermovate should be gradually withdrawn by reducing the frequency of application of the cream / ointment or replacing it with a less potent corticosteroid, taking into account the risk of glucocorticosteroid insufficiency. Further treatment is carried out in accordance with the patient's condition or according to national recommendations for the treatment of poisoning.

Storage conditions

At temperatures up to 30 °C.

Information for the professional activities of medical and pharmaceutical workers.

$23.09 BUY ONLINE
MORE

$31.49 - Almagel oral suspension 170 ml — Made in Bulgaria — Free Delivery

BALKANPHARMA-TROYAN #Digestive_system #Stomach_ulcers_heartburn_acid_reflux #HEALTH_CARE

Pharmacological properties

Pharmacodynamics. Almagel is a balanced combination of aluminum hydroxide and magnesium hydroxide. The preparation has an antacid effect when using the recommended one-time (40-60 minutes after eating) or a daily dose during the day. Aluminum hydroxide neutralizes the increased secretion of hydrochloric acid and reduces the activity of pepsin in the stomach, forming aluminum chloride, which, under the influence of the alkaline contents of the intestine, turns into alkaline aluminum salts. they are poorly absorbed and practically do not change the concentration of aluminum salts in the blood with a short use of Almagel (15–20 days). Aluminum hydroxide reduces the concentration of phosphates by binding phosphate ions in the intestine and thus limiting their absorption. the use of the preparation does not cause alkalosis and does not contribute to the formation of co2 in the stomach. Magnesium hydroxide also neutralizes hydrochloric acid in the stomach, converting to magnesium chloride, which has a mild laxative effect.

Almagel, like other antacids containing aluminum, exhibits a cytoprotective effect on the gastric mucosa, due to the stimulation of prostaglandin synthesis. This increases its resistance and protects against necrotic inflammatory and erosive-hemorrhagic lesions due to the use of irritating and ulcerogenic agents such as acetylsalicylic acid, NSAIDs, ethanol. On the other hand, aluminum hydroxide exhibits a pronounced astringent and anti-inflammatory effect on the inflamed mucous membrane of the stomach and duodenum when the preparation is used 10-15 minutes before meals.

Sorbitol has a mild carminative and moderate choleretic effect, as well as a moderate laxative effect, which compensates for the tendency to constipation in most patients under the influence of aluminum hydroxide.

Pharmacokinetics. Aluminum salts are absorbed slightly in the intestines and excreted in the feces. With normal renal function, the plasma level of aluminum remains practically unchanged. Magnesium ions are absorbed only by 10%, and their concentration in the blood remains almost unchanged. The duration of action depends on the rate of gastric emptying. When applied on an empty stomach, it varies from 20 to 60 minutes. When applied 1 hour after a meal, the antacid effect can last up to 3 hours.

Indications

(Symptomatic treatment of diseases of the digestive tract, accompanied by increased acidity of gastric juice, such as esophagitis, hiatal hernia, gastroesophageal reflux disease, acute and chronic gastritis, gastroduodenitis, gastric ulcer and duodenal ulcer, gastroesophageal gastrointestinal tractitis and reflux disease) ...

Prophylactically to reduce the irritating and ulcerogenic effect of certain preparations on the mucous membrane of the esophagus, stomach and duodenum (for example, corticosteroids, NSAIDs).

Application

Symptomatic treatment of diseases of the digestive tract, accompanied by increased acidity of gastric juice. adults and children over the age of 14 years - 5-10 ml (1-2 scoops) 3 times a day or 1 sachet 3 times a day. if necessary, a single dose can be increased to 15 ml - 3 measuring (dosage) spoons. after reaching the therapeutic effect, the dose should be reduced to 5 ml 3-4 times a day for 2-3 months. within 15 minutes after using the preparation, you should not drink water.

In order to achieve a symptomatic antacid effect, Almagel is usually used 45-60 minutes after meals and in the evening before bedtime.

For prevention. Adults and children over the age of 14 years - 5-15 ml (1-3 scoops) or 1 sachet 15 minutes before taking medications that irritate the mucous membrane of the esophagus, stomach or duodenum. For children aged 10-14 years, give half the dose recommended for adults. The recommended duration of treatment is 12 days.

In the case of prescribing the preparation in a single dose of 5 or 15 ml, it is recommended to use Almagel in vials, since this type of packaging provides a dosage spoon, which makes it possible to accurately measure the required volume of the preparation.

Before use, the suspension must be thoroughly homogenized by shaking the bottle or kneading the sachet. Measurement of the required amount of the preparation from the vial occurs using the dosage spoon, which is contained in the kit. When using the preparation in sachets, the following recommendations must be observed: keep the package upright, cut or tear off one of the corners in the designated place. Pour the contents of the sachet through the opening of the sachet into a spoon or directly into the mouth.

Patients with renal impairment. When treating patients with impaired renal function, it is necessary to reduce the dose or increase the interval between doses.

Children. Do not use in children under 10 years of age due to the impossibility of accurate dosing.

Contraindications

The preparation is not recommended for use in case of hypersensitivity to its components, habitual constipation, Alzheimer's disease, intense abdominal pain of unspecified origin, suspected acute appendicitis, the presence of ulcerative colitis, colostomy or ileostomy, with chronic diarrhea, hemorrhoids, severe renal failure, hypophosphatemia, in lactation period.

Side effects

From the gastrointestinal tract: manifestations of constipation are possible, which disappear when the dose is reduced, diarrhea; discoloration of feces, nausea, vomiting, stomach cramps;

laboratory indicators: most often in patients with renal failure and in the case of prolonged use or taking the preparation in high doses due to hypermagnesemia, hyperaluminaemia, intoxication with magnesium and aluminum develops; hypophosphatemia (manifestations of which may be decreased appetite, muscle weakness, weight loss); possible hypocalcemia, hypercalciuria;

from the kidneys and urinary tract: nephrocalcinosis, impaired renal function;

hypersensitivity reactions: local and general allergic reactions, including pruritus, urticaria, angioedema and anaphylactic reactions, bronchospasm;

from the side of the central nervous system: with prolonged use of the preparation in patients with renal failure and patients on dialysis, manifestations of encephalopathy, neurotoxicity (changes in mood and mental activity) are possible; dementia, disorders of the condition in Alzheimer's disease;

on the part of the musculoskeletal system: osteoporosis; with prolonged use of the preparation in high doses against a background of phosphorus deficiency in food, osteomalacia may occur;

others: change in taste.

With prolonged use of the preparation in patients with renal failure and in patients on dialysis, manifestations of thirst, a decrease in blood pressure, hyporeflexia, and the development of microcytic anemia are possible.

Special instructions

It is not recommended to use the preparation in patients with diverticulosis, violations of acid-base balance in the body in the presence of metabolic alkalosis, with cirrhosis of the liver, severe heart failure, toxicosis of pregnant women, renal disorders (due to the risk of developing hypermagnesemia and aluminum intoxication).

Patients should consult a doctor in case of weight loss, difficulty swallowing or persistent abdominal discomfort, new-onset digestive disorders, or if the course of existing digestive disorders changes.

Aluminum hydroxide can lead to constipation, and magnesium hydroxide can lead to intestinal hypokinesia. The use of this preparation in high doses can cause or worsen bowel obstruction and intestinal obstruction, especially in patients at increased risk of such complications, such as those with renal insufficiency or elderly patients.

The use of antacids containing aluminum in elderly patients should be limited. With prolonged use in elderly patients, the condition of existing diseases of the bones and joints may worsen.

With prolonged use of the preparation, it is necessary to ensure that a sufficient amount of phosphorus is supplied to the body, since aluminum hydroxide binds to phosphates and reduces their absorption from the digestive tract. The excretion of calcium in the urine increases, which can lead to disturbances in calcium-phosphate balance and create conditions for the development of osteomalacia (symptoms are complaints of weakness and pain in the bones). Aluminum hydroxide can be hazardous when used in patients with porphyria on hemodialysis.

With prolonged use (14 days), regular monitoring by a physician and monitoring of the plasma levels of magnesium and aluminum is necessary in the treatment of patients with renal insufficiency. In this category of patients, it is also necessary to monitor the dynamics of the indicators of the state of the kidneys, the size of the ulcer, the appearance of diarrhea.

During treatment, it is not recommended to consume alcohol and caffeine due to a decrease in the effect of the preparation.

Excipients. The preparation contains sorbitol, which allows diabetic patients to take it, but should not be used in patients with congenital fructose intolerance, as this can cause stomach irritation and diarrhea.

The preparation contains parabens, which can provoke urticaria and very rarely - allergic reactions of an immediate type - bronchospasm.

The preparation contains ethyl alcohol, as a result of which complications may occur in patients with liver and brain diseases, in patients with epilepsy and alcoholism, in pregnant women and children under 10 years of age.

Use during pregnancy and lactation. There are no data from clinical studies on the use of Almagel in pregnant women, therefore, the preparation is not recommended for use during pregnancy. If necessary, Almagel can be used during pregnancy only as directed by a doctor, if the expected benefit to the mother outweighs the possible risk to the fetus / child. In this case, the preparation is recommended to be used for no more than 5-6 days and only under medical supervision.

The content of aluminum and magnesium ions that can affect the transit of gastrointestinal contents should be taken into account, namely:

magnesium hydroxide salts can cause diarrhea;

aluminum salts can cause constipation, which can worsen the course of constipation, which often occurs during pregnancy, therefore, prolonged use and excess doses of the preparation should be avoided.

The preparation is not recommended to be prescribed for toxicosis of pregnant women.

Lactation. There is no data on the ability of the active substances of the preparation to penetrate into breast milk, therefore, if treatment is necessary, breastfeeding should be discontinued.

The ability to influence the reaction rate when driving or working with other mechanisms. Ethanol contained in the preparation in the indicated amount cannot affect the ability to drive vehicles or operate machinery when taken in recommended daily doses.

Interactions

The interval between the use of Almagel and other medicines should be ≥1–2 hours.

Almagel changes the acidity of the contents of the stomach, which affects absorption, bioavailability, maximum plasma concentrations, as well as the elimination of most preparations when used simultaneously.

Almagel reduces the absorption of digoxin, indomethacin, salicylates, chlorpromazine, phenytoin, reserpine, H2-receptor blockers (cimetidine, ranitidine, famotidine), lansoprazole, β-adrenergic receptor blockers (for example, atenolol, metoprolatov, chlorofluorone) quinolones (ciprofloxacin, norfloxacin, ofloxacin, enoxacin, grepafloxacin), azithromycin, cefpodoxime, pivampicillin, rifampicin, indirect anticoagulants, barbiturates, fexofenadine, sodium fluoride, dipyridoxidamole, bile acid iron, lithium preparations, quinidine, mexiletine, phenothiazine preparations, tetracycline antibiotics, lincosamides, phosphorus (additives), anti-tuberculosis preparations (ethambutol, oral isoniazid), chloroquine, glucocorticoid preparations (known to interact with prednisolone) and ceksayetazelate ola. Therefore, if possible, the time interval between taking Almagel and these preparations should be 2 hours.

The lower absorption of these preparations is associated with the formation of insoluble complexes and / or alkalization of the stomach contents.

With the simultaneous use of enteric-soluble preparations, the increased alkalinity of gastric juice can lead to accelerated destruction of their membrane and cause irritation of the stomach and duodenum.

Blockers of M-cholinergic receptors slow down gastric emptying and enhance, prolong the action of Almagel.

Excretion of quinidine with manifestations of quinidine toxicity may be impaired, especially in patients with renal insufficiency. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in the level of aluminum, especially in patients with renal insufficiency. The preparation can reduce the absorption of folic acid.

When combined with levothyroxine, its hormonal effect may be reduced.

Pirenzepine enhances and prolongs the action of Almagel.

Impact on laboratory research. Almagel can affect the results of some laboratory and functional studies and tests: it reduces the level of gastric secretion when determining its acidity; violates the test of visualization of diverticula and bone scintigraphy using technetium (99Tc); moderately and for a short time increases the plasma level of gastrin, increases the plasma level of phosphorus, the pH of blood plasma and urine.

Overdose

With a single accidental intake of the preparation in a high dose, there are no other signs of an overdose other than constipation, flatulence, a feeling of a metallic taste in the mouth.

With prolonged use of the preparation in high doses, the formation of kidney stones, the appearance of severe constipation, abdominal pain, drowsiness, and hypermagnesemia are possible. Signs of metabolic alkalosis may also occur - changes in mood or mental activity, numbness or muscle pain, nervousness or fatigue, slow breathing, unpleasant taste sensations.

Treatment: it is necessary to immediately take measures for the rapid elimination of the preparation - rinse the stomach, induce vomiting, take enterosorbents. In case of an overdose of magnesium, rehydration and forced diuresis are recommended. You can use calcium gluconate IV. In case of renal failure, hemodialysis or peritoneal dialysis is necessary.

Storage conditions

Store at ≤25 ° c in original packaging. do not freeze.

$31.49 BUY ONLINE
MORE

$27.29 - Babe Laboratorios Purifying cleansing gel 200 ml — Made in Spain — Free Delivery

Babe Laboratorios #For_face #Cleansing_gel #COSMETICS

Product description

BABE LABORATORIOS Purifying cleansing gel removes impurities and helps control excess sebum and shine of the facial skin.

Gently cleanses without causing irritation thanks to its synthetic detergent composition.

Designed for oily / acne prone skin.

Properties

Babe Purifying cleansing gel:

helps control excess sebum
opens pores preventing acne formation
helps to stop the spread of bacteria
reduces foci of inflammation
removes shine from the skin and makes it matte

Composition

Active ingredients: cytobiol iris 2%, salicylic acid 0.20%, zinc salt of pyrrolidone-carboxylic acid 0.02%.

Mode of application

Apply morning and evening to face and neck, then rinse.

Avoid contact with eyes.

Specifications

Type: face gel

Purpose: cleansing, matting

Application time: universal

Age: 16+

Gender: unisex

Skin type: oily, problematic, acne-prone

Package Quantity: 200 ml

$27.29 BUY ONLINE
MORE

$15.74 - 2 x HERPEX CREAM 0.05G/1G 2 G - MADE IN POLAND - FREE SHIPPING

SANDOZ #Dermatology #Diseases #Herpes #HEALTH_CARE

Product description

Herpex is an antiviral preparation in the form of a cream intended for topical application, the active substance of which is acyclovir. This substance is highly active against herpes simplex viruses (HSV) types 1 and 2, and against varicella-zoster viruses (VZV). The preparation has no systemic effects, but only local effects on a small area of the skin at the application site. It can be used on the affected skin of the lips and genitals.

Indications

Treatment of skin infections caused by Herpes simplex viruses 1 and 2.

Composition

1 g of cream contains:

active ingredient: acyclovir 50 mg,

other ingredients: macrogolglycerides, stearates, dimethicone 350, cetyl alcohol, white petroleum jelly, liquid paraffin, propylene glycol, purified water.

Action

The preparation is active against herpes simplex viruses (HSV) types 1 and 2 and against varicella-zoster viruses (VZV).

Dosage

A thin layer of cream should be applied to the infected skin area 5 times a day every 4 hours, keeping the night break. The preparation should be applied with a cosmetic stick to the affected areas and the adjacent skin surface. If you apply the preparation directly with your fingers, wash your hands thoroughly before and after applying it to avoid contamination of the affected skin or spreading the herpes virus to uninfected mucosa and skin.

The most common period of use is 5 days, but it should not exceed 10 days. If the skin lesions have not healed, treatment should be continued until the lesions heal or form scabs. The preparation is most effective when used immediately after the first symptoms of herpes infection, such as burning, itching, a feeling of tightness and redness, appear. The use of the preparation when the scabs are exhausted is not effective.

Contraindications

The preparation should not be used if the patient is allergic to:

acyclovir,

valaciclovir,

propylene glycol or any of its other ingredients.

Storage

Keep the preparation out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date is the last day of a given month.

Medicines should not be disposed of via wastewater or household waste. Ask the pharmacist how to dispose of medicines no longer needed. Such behavior will help to protect the environment.

Side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Uncommon side effects are: temporary burning or stinging sensation, slight dryness or peeling of the skin, itching.

Rare side effects are erythema and contact dermatitis.

Very rare side effects are immediate hypersensitivity reactions, including angioedema and urticaria.

Interactions

Inform about all medications taken by the patient now or recently, including those that he plans to take, even if they are medications that are not prescribed by a physician.

Significant interactions with other preparations are unknown.

Warnings and Precautions

The preparation may irritate the mucous membranes, so it must not be used in the mouth, around the eyes or in the vagina.

Avoid contact of the preparation with the eyes.

The paraffin and petroleum jelly contained in the preparation may reduce the safety of condom use when applied to the genitals and around the anus.

Patients with severely impaired immune systems should consult a physician before taking the preparation, who may advise them to take oral aciclovir.

If a woman is pregnant, she suspects that she may be pregnant or is planning a pregnancy before starting the preparation.

Herpex should be used during pregnancy only if, in the doctor's opinion, the benefit of the medicine by the mother outweighs the potential risk to the baby.

Aciclovir may pass into breast milk, but the dose received by the infant in the milk of the mother using aciclovir cream is negligible.

The propylene glycol contained in the preparation may irritate the skin, and ethyl alcohol may cause local skin reactions, such as contact dermatitis.

$15.74 BUY ONLINE
MORE

$37.79 - PADMA BASIC 100 CAPS - MADE IN POLAND- FREE SHIPPING

TYMOFARM #The_immune_system #Other_immune_preparations #HEALTH_CARE

Product description

Padma Basic is a blend of original herbs, produced in Switzerland according to a traditional Tibetan recipe.

Application

Supplementing the diet with active ingredients of the preparation.

Recommended intake

1-4 capsules a day, preferably before a meal.

Ingredients

Gelatin (shell), costus root, Icelandic moss, Indian honey fruit, cardamom fruit, almond fruit, red sandalwood fruit, root fruit, aegle sepiar fruit, bulking agent (calcium sulphate), spotted eagle herb, licorice root, plantain herb, herb knotweed, cinquefoil, carnation flower, hedychii quadruple, sida cordifolia, valerian root, lettuce leaf, calendula flower, natural camphor, anti-caking agent (silicon dioxide).

1 capsule contains: costus root 40mg, Icelandic moss 40mg, Indian honey fruit 35mg, cardamom fruit 30mg, almond fruit 30mg, red sandalwood 30mg, root fruit 25mg, aegle sepiar fruit 20mg, spotted eagle herb 15mg, licorice root 15mg, plantain herb 15mg, knotweed herb 15mg, cinquefoil herb 15mg, clove flower 12mg, hedychii rhizome 10mg, sida cordifolia 10mg, valerian root 10mg, lettuce leaf 6mg, calendula flower 5mg, natural camphor 4mg.
2 capsules contain: costus root 80mg, Icelandic moss 80mg, Indian honey fruit 70mg, cardamom fruit 60mg, almond fruit 60mg, red sandalwood 60mg, root fruit 50mg, aegle sepiar fruit 40mg, spotted eagle herb 30mg, licorice root 30mg, plantain herb 30mg, knotweed herb 30mg, cinquefoil herb 30mg, clove flower 24mg, hedychii rhizome 20mg, sida cordifolia 20mg, valerian root 20mg, lettuce leaf 12mg, calendula flower 10mg, natural camphor 8mg.
3 capsules contain: costus root 120mg, Icelandic moss 120mg, Indian honey fruit 105mg, cardamom fruit 90mg, almond fruit 90mg, red sandalwood 90mg, root fruit 75mg, aegle sepiar fruit 60mg, spotted eagle 45mg, licorice root 45mg, plantain herb 45mg, knotweed 45mg, cinquefoil 45mg, clove flower 36mg, hedychii rhizome 30mg, sida cordifolia 30mg, valerian root 30mg, lettuce leaf 18mg, calendula flower 15mg, natural camphor 12mg.
4 capsules contain: costus root 160mg, Icelandic moss 160mg, Indian honey fruit 140mg, cardamom fruit 120mg, almond fruit 120mg, red sandalwood 120mg, root fruit 100mg, aegle sepiar fruit 80mg, spotted eagle herb 60mg, licorice root 60mg, plantain plantain herb 60mg, knotweed herb 60mg, cinquefoil herb 60mg, clove flower 48mg, hedychii rhizome 40mg, sida cordifolia 40mg, valerian root 40mg, lettuce leaf 6mg, calendula flower 20mg, natural camphor 16mg.

Important tips

Do not exceed recommended servings for consumption during the day.

The product cannot be used as a substitute for a varied diet and a healthy lifestyle.

A balanced diet. A proper lifestyle is important for the functioning of the human body.

The preparation should be stored in a dry place at room temperature, out of the reach of small children.

The use in pregnant women is not recommended.

In case of difficulties with swallowing, the capsule can be opened and the contents mixed with water, juice or fruit mousse.

$37.79 BUY ONLINE
MORE

$20.99 - Lirene Perfect Tan, bronzing body foam, Espresso, 150 ml — Made in Poland — Free Delivery

Dr. Irena Eris #Sunbathing #Bronzing_cosmetics #COSMETICS

Product description

Lirene Perfect Tan Expresso bronzing body foam contains a specially developed formula, which was created for active people. The strengthened formula will not disappear during exercise and will last up to 5 days.

The foam is quickly absorbed and evenly spreads over the skin, without leaving streaks or uneven discoloration on its surface. The effect of a natural, golden tan is visible after an hour after applying the cosmetic. The vegan composition of the foam also includes ingredients that care for the body:

Organic coconut water intensely moisturizes and nourishes.

Ecological acai extract regenerates, smoothes and prevents the loss of firmness and elasticity of the skin.

Lirene Perfect Tan bronzing body foam makes the skin of your body smooth and soft to the touch, and the care is completed with a pleasant coffee scent.

Application

The foam gives the skin the effect of a healthy golden tan and thanks to the active ingredients it contains, it becomes intensely moisturized and pleasantly soft to the touch.

Usage method

Apply a small amount of Lirene Perfect Tan bronzing foam evenly on the skin, 1-2 times a week (or more often) depending on the desired tan intensity.

Wash your hands after application.

Ingredients (INCI)

Aqua (Water), Dihydroxyacetone, Glycerin (glycerin), PEG-40 Hydrogenated Castor Oil, Cocamidopropyl Betaine, Coco-Glucoside, Cocos Nucifera Water (coconut water), Euterpe Oleracea Fruit Extract (acai extract), Calcium Gluconate, Citric Acid, Gluconolactone, Sodium Benzoate, Potassium Sorbate, Parfum (Fragrance), Benzyl Benzoate.

Additional information

Vegan cosmetic.

97% of the ingredients are of natural origin.

The foam leaves no traces on clothing.

A tan after a single use of the foam lasts up to 5 days.

$20.99 BUY ONLINE
MORE